Objective: To investigate the influencing factors for anxiety symptoms among human papilloma virus (HPV)-infected women, so as to provide the evidence to improve the mental health of HPV-infected women. Methods: HPV-infected women visiting the gynecology department of a tertiary hospital in Urumqi from September to December 2024 were selected using a convenience sampling method. Basic information of HPV-infected women and information related to HPV infection were collected through a self-designed questionnaire. Anxiety symptoms was assessed by using the Generalized Anxiety Disorder-7 (GAD-7), with a GAD-7 score of ≥5 determined to be the presence of anxiety symptoms. Factors affecting anxiety symptoms in HPV-infected women were analyzed using a multivariable logistic regression model. Results: A total of 436 HPV-infected women were investigated. Among them, 361 (82.80%) were aged 30-<60 years old, 286 (65.60%) had a high school/technical secondary school or above, 361 (82.80%) had a spouse, 389 (89.22%) had given birth, and 234 (53.67%) had a family monthly income of less than 5 000 yuan. There were 90 HPV-infected women with multiple HPV infections, accounting for 20.64%. The sexual life of 155 people was affected, accounting for 35.55%. A total of 165 HPV-infected women with anxiety symptoms were detected, with a detection rate of 37.84%. Multivariable logistic regression analysis showed that multiple HPV infections (OR=1.776, 95%CI: 1.068-2.954), HPV infection time <3 months (OR=1.858, 95%CI: 1.132-3.050), lack of HPV-related knowledge (OR=1.742, 95%CI: 1.045-2.905), sexual life was affected (OR=3.480, 95%CI: 2.146-5.642), and monthly family income was less than 5 000 yuan (OR=1.815, 95%CI: 1.119-2.946) had a higher risk of anxiety symptoms Conclusions The detection rate of anxiety symptoms in HPV-infected women is high. The type of HPV infection, the duration of HPV infection, the understanding of HPV-related knowledge, the impact on sexual life, and the monthly family income are influencing factors of anxiety symptoms among HPV-infected women.